Ignite Creation Date:
2025-12-24 @ 9:50 PM
Ignite Modification Date:
2026-01-05 @ 5:17 PM
Study NCT ID:
NCT07228832
Status:
RECRUITING
Last Update Posted:
2025-11-14
First Post:
2025-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor:
Summit Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-10
First Submit QC Date:
None
Study First Post Date:
2025-11-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-13
Last Update Post Date:
2025-11-14
Last Update Post Date Type:
ESTIMATED